Effects of Supplemental Sini San on Hepatic Function and Liver Fibrosisin in Rat Hepatic Fibrosis Model

WANG Fu; SHANG Li-zhi; MIAO Xiao-ling; GAN Chen-fei; ZHANG Hui-na

您当前的位置：

首页 >

文章列表页 >

Effects of Supplemental Sini San on Hepatic Function and Liver Fibrosisin in Rat Hepatic Fibrosis Model

更新时间：2024-01-04

- Effects of Supplemental Sini San on Hepatic Function and Liver Fibrosisin in Rat Hepatic Fibrosis Model
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 18, Issue 5, Pages: 177-180(2012)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2012
- 稿件说明：
移动端阅览
WANG Fu, SHANG Li-zhi, MIAO Xiao-ling, et al. Effects of Supplemental Sini San on Hepatic Function and Liver Fibrosisin in Rat Hepatic Fibrosis Model[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(5): 177-180.
DOI：

WANG Fu, SHANG Li-zhi, MIAO Xiao-ling, et al. Effects of Supplemental Sini San on Hepatic Function and Liver Fibrosisin in Rat Hepatic Fibrosis Model[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(5): 177-180. DOI：

摘要

目的: 探讨四逆散加味对大鼠肝纤维化的防治作用。方法: 80只Wister大鼠随机分为8组:正常对照组、病理模型对照组、秋水仙碱治疗组、四逆散对照组、四逆散加味高、中、低剂量组、四逆散预防组。除正常对照组外

其余各组均采用猪血清ip诱发肝纤维化

0.5 mL/只

2次/周

连续10周

5周后即可形成肝纤维化。预防组于造模同时给药(以四逆散加味7 g·kg-1)

各治疗组于造模第6周给药

四逆散组4 g·kg-1

四逆散加味高、中、低剂量组(14

3.5 g·kg-1)

连续10周。全自动分析法测定各组血清肝功能、放射免疫法测定血清肝纤维化指标

酸性水解法检测肝组织羟脯氨酸(HYP)含量

观察病理变化。结果: 与模型组比较

四逆散加味中剂量组大鼠血清中丙氨酸转氨酶·L-1(138.88±21.52)

(75.20±3.80)

(P<0.05)]、天冬氨酸转氨酶·L-1

(375.25±10.95)

(227.10±19.08)

(P<0.05)]、碱性磷酸酶 (ALP

P<0.05)、透明质酸·L-1(258.10±32)

(135.26±34.09)

(P<0.05)]、Ⅲ型胶原·L-1(105.28±15.31)

(85.32±9.53)

(P<0.05)]、Ⅳ型胶原·L-1(109.10±8.31)

(86.48±19.17)

(P<0.05)]、层黏连蛋白 (LN

P<0.05)含量均显著下降

肝组织HYP

(P<0.01)含量显著降低。结论: 四逆散加味有明显的抗肝纤维化作用。

Abstract

Objective: To investigate the protective effects and its mechanism of supplemental Sini San on hepatic fibrosis in rats. Method: The immunohepatic fibrosis model was induced by intraperitoneal injection of porcine serum.in to rats.Eighty Wister rats were divided into eight groups: normal control group

model control group

prevention group(7 g·kg-1)

high dose group (14 g·kg-1)

mediate dose group (7 g·kg-1)

and low dose group (3.5 g·kg-1)of supplemental Sini San

colchicin control group (0.2 mg·kg-1)

Sini San control group(4 g·kg-1). Except the normal control group

all the other groups were injected with pig serum without inactivation into abdominal cavity

twice per week and 0.5 mL each time

lasting 10 weeks. The prevention group was given supplemental Sini San

10 weeks at the same time when establishment of models began

the other groups were treated with correspoding drugs after 6 weeks of modelling

and lated 10 weeks.The changes of the biochemical indicator in serum and hepatic fibrosiswere were detected respectively. Result: Compared with model group

the serum content of alanine aminotransferase(ALT)

aspartate aminotransferase(AST)

r-glutamyl transpeptadase(GGT)

alkaline phosphatase(ALP) and typeⅠ

Ⅲ

Ⅳcollage

hyaluronic acid (HA)

laminin(LN) were depressed obviously

the content of hydroxyproline (HYP) in liver tissuewas significantly lower in supplemental Sini San mediatedose group. Conclusion: Supplemental Sini San has a treatment;action on hepatic fibrosis model rats.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Therapeutic Effect of Gantai Capsules on CCl-induced Liver Fibrosis in Rats

Protective Effect of Extracts from Astragali Radix on Liver Fibrosis Induced by CCl in Rats

Effects and Mechanism of Supplemental Sini San on Hepatic Fibrosis in Rats

Effect of Water Extract of on Liver Fibrosis Rat Models Induced by Carbon Tetrachloride

Effect of Xiaozhang Recipe on Liver Fibrosis Induced by Carbon Tetrachloride in Rats

Related Author

LI Guang-quan

LIU Hui-min

CUI He-rong

ZHANG Zhen-fang

SANG Xiu-xiu

WANG Jia-kui

BAI Zhao-fang

LI Cheng-hao

Related Institution

Department of Physiology,Henan University of Traditional Chinese Medicine

Henan General Hospital

The First Affiliated Hospital of Henan University of Chinese Medicine

The First Clinical Medical College of Henan University of Chinese Medicine

Graduate School of Anhui University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰